Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
GLP1 + Cagrilintide Research Administration Common Study Populations Clinical trials have enrolled diverse participant groups: Adults with obesity BMI 30 kg/m squared or greater without diabetes (REDEFINE 1) Adults with overweight and comorbidities BMI 27 kg/m squared or greater with at least one weight-related condition Adults with type 2 diabetes BMI 27 kg/m squared or greater with established diabetes (REDEFINE 2) Age range Primarily adults aged 18-75 years across trials Geographic diversity Multi-national trials across North America, Europe, Asia, and other regions Exclusion criteria typically included type 1 diabetes, recent cardiovascular events, severe renal or hepatic impairment, history of pancreatitis, and medications causing significant weight changes
Nausea is the most frequent side effect, typically emerging within hours to days of the first injection and often improving after 24 weeks as your body adjusts
This is why correcting your technique matters, not because one mistake will ruin everything, but because consistent subcutaneous delivery produces the best long-term results
Since the liver and kidneys work in tandem to process and remove waste, supporting one often helps the other
US$ 24.90
US$ 27.95
US$ 25.40
